Notice Regarding the Sale of Real Estate Held for Sale by a Consolidated Subsidiary | EnBio Holdings,Inc (6092) timely disclosure

Worth reading

37Immaterial

0–100. This measures how worthwhile something is to read, not how good or bad the company is.

Direction

Neutral

Direction inferred from the company’s description.

Scale

At least 10% of consolidated net sales for the immediately preceding fiscal year (the fiscal year ended March 2026)

Wording

Conditional

How definitive the wording is.

Sale of real estate held for sale

Subject Entity

株式会社土地再生投資 (consolidated subsidiary)

Target Locations / Products

Land in Midorigaoka-nishi, Yachiyo, Chiba Prefecture, 15,233.53 m² (as recorded in the registry)

Occurrence30 October 2026 (date of the Board of Directors' resolution approving the sale and date of contract execution)

This disclosure10/30/2026

Amount of Impact on Business Performance

The sale price is undisclosed. Expected sales revenue is at least an amount equivalent to 10% of consolidated net sales for the immediately preceding fiscal year (the fiscal year ended March 2026).

Accounting period in which recognized

Scheduled during the fiscal year ending March 2028

Impact on Earnings Forecast

The sale will not affect consolidated results for the fiscal year ending March 2027.

Outlook

The sale is scheduled during the fiscal year ending March 2028. Settlement and property delivery are scheduled for 4 June 2027.

Event that occurred
Item	Details
Event name	Sale of real estate held for sale
Date of occurrence	30 October 2026 (date of the Board of Directors' resolution approving the sale and date of contract execution)
Subject Entity	株式会社土地再生投資 (consolidated subsidiary)
Target Locations / Products	Land in Midorigaoka-nishi, Yachiyo, Chiba Prefecture, 15,233.53 m² (as recorded in the registry)
Amount of Impact on Business Performance	The sale price is undisclosed. Expected sales revenue is at least an amount equivalent to 10% of consolidated net sales for the immediately preceding fiscal year (the fiscal year ended March 2026).
Accounting period in which recognized	Scheduled during the fiscal year ending March 2028
Impact on Earnings Forecast	The sale will not affect consolidated results for the fiscal year ending March 2027.
Outlook	The sale is scheduled during the fiscal year ending March 2028. Settlement and property delivery are scheduled for 4 June 2027.

Items this document does not state (17)

Date recognized / date notice receivedCauseType of litigation or proceedingCourt or authorityPlaintiffDefendantDate of filing / date of actionClaim amount / surcharge amountAmount of receivables at risk of non-collection or delayed collectionSuspended operationsScheduled resumption dateInvestigation structureMeasures to prevent recurrenceDirectors' and officers' liabilityVoting rights ownership percentage before the changeVoting rights ownership percentage after the changePlanned follow-up disclosure

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

No reason for the sale is stated. The non-disclosure of the sale price and buyer is attributed to a confidentiality agreement with the buyer.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.

Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.

Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.